Have multiple conditions? Click here

New Clinical Trials for Asthma

Although more testing is needed, clinical studies show an association between 100 genes and asthma. This fact gives researchers a lot to consider when conducting asthma clinical trials. It indicates that there may be a way to counter asthma before it becomes a problem. It means there may one day be a cure rather than simply treating asthma symptoms.
 
If you or someone you know suffer from asthma please review our list of current asthma clinical trials. If you qualify you may be able to participate in a clinical trial to help us learn more about asthma, its causes and possible cures.
 

What is Asthma?

Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma include shortness of breath, tightness in the chest, wheezing, coughing, and trouble sleeping. Asthma is linked to a combination of genetic and environmental factors. Environmental factors include allergens such as smoke, dust, air quality, and pets. There has been a sharp increase in asthma since the 1970’s and as of 2009 over 300 million people worldwide are affected by it. Types of asthma include brittle asthma, asthma attack, status asthmaticus, and occupational asthma
 

Asthma Treatments

Treating asthma is done best with a specific plan of management based on the patient’s symptoms. The easiest way to treat asthma is to avoid the triggers; however, this is not always possible. There are two main forms of medications used for treating asthma – quick relief and long term. Quick relief medications often come in the form of inhalers and can be used to provide fast relief in case of a flare up. Long term medications generally last 12 – 24 hours and aim to prevent asthma attacks.
 
Unfortunately manual therapies such as osteopathic, chiropractic and respiratory therapeutic maneuvers have not proven effective. There is not enough evidence to support these as successful treatments for asthma.

Have multiple conditions? Click here

Showing 1-100 of 753
There are 753 Asthma Clinical Trials
Name City State Zip
Asthma Clinical Trial Birmingham AL 35216
Asthma Clinical Trial Birmingham AL 35216
Asthma Clinical Trial Birmingham AL 35216
Asthma Clinical Trial Port Orange FL 32129
Asthma Clinical Trial DeLand FL 32720
Lansoprazole to Treat Children With Asthma Birmingham AL 35233
TC-6987 for the Treatment of Mild to Moderate Asthma Birmingham AL 35209
A Non-drug Study Profiling Asthma Birmingham AL
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma Birmingham AL
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Tucson AZ 85724
The Study of Soy Isoflavones in Asthma Tucson AZ 85721
BI 671800 ED in Steroid-naive Asthmatic Patients Tucson AZ
Study of Asthma and Nasal Steroids Tucson AZ 85721
TC-6987 for the Treatment of Mild to Moderate Asthma Scottsdale AZ 85251
Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM Scottsdale AZ 85251
Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM Phoenix AZ 85016
Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM Phoenix AZ 85004
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma Phoenix AZ
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Little Rock AR 72205
Telemedicine Education for Rural Children With Asthma Little Rock AR 72202
Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma Little Rock AR
Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children Little Rock AR 72202
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Fayetteville AR 72703
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Fayetteville AR 72703
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma Walnut Creek CA 94598
Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults? Vallejo CA 94589
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma Sylmar CA 91342
BI 671800 ED in Steroid-naive Asthmatic Patients Stockton CA
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II Stockton CA
Healthier Living Canada Stanford CA 94305
An Observational Study of the Use and Safety of Xolair During Pregnancy South San Francisco CA 94080
Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma Santa Rosa CA 95405
BI 671800 ED in Steroid-naive Asthmatic Patients San Jose CA
Use of a Probiotic Supplement to Prevent Asthma in Infants San Francisco CA 94115
Histoblood Group Antigens as a Risk Factor of Asthma San Francisco CA 94115
Lansoprazole to Treat Children With Asthma San Francisco CA 94143
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma San Francisco CA 94143
Analysis of Blood-based Biomarkers of Asthma San Francisco CA 94143
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities San Francisco CA 94143
The Study of Soy Isoflavones in Asthma San Francisco CA 94110
Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma San Francisco CA 94143
Study of Asthma and Nasal Steroids San Francisco CA 94110
TC-6987 for the Treatment of Mild to Moderate Asthma San Diego CA 92120
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. San Diego CA 92121
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma San Diego CA 92103
Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults? San Diego CA 92120
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART) San Diego CA
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy San Diego CA
Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma San Diego CA
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I San Diego CA
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients San Diego CA
A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma San Diego CA
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma San Diego CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Redwood CA 94063
TC-6987 for the Treatment of Mild to Moderate Asthma Palmdale CA 93551
BI 671800 ED in Steroid-naive Asthmatic Patients Palmdale CA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Orange CA 92868
Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma Orange CA 92868
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma Orange CA 92868
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma Oakland CA
Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma Mission Viejo CA 92691
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Mission Viejo CA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Madera CA 93638
Mentored Patient-Oriented Research Career Development Award Los Angeles CA 90095
Problem-Solving Skills Training to Improve Care for Children With Asthma Los Angeles CA 90027
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma Los Angeles CA 90033
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma Los Angeles CA 90033
Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma Los Angeles CA 90025
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Los Angeles CA 20027
BI 671800 ED in Steroid-naive Asthmatic Patients Los Angeles CA
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II Los Angeles CA
Study of ACT-129968 in Adult Patients With Partly Controlled Asthma. Los Angeles CA 90025
Study of ACT-129968 in Adult Patients With Partly Controlled Asthma. Los Angeles CA 90095
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis Los Angeles CA 90027
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Long Beach CA 90808
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma Lakewood CA 90712
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma Lakewood CA 90712
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma LaJolla CA 92037
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma Huntington Beach CA
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Huntington Beach CA
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma Fountain Valley CA 92708
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Cypress CA 90630
BI 671800 ED in Steroid-naive Asthmatic Patients Cypress CA
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma Buena Park CA 90620
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma Anaheim CA 92805
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma Anaheim CA 92807
Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics Anaheim CA 92807
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily Anaheim CA 92807
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Anaheim CA 92807
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Anaheim CA 92807
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics Anaheim CA 92807
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma Anaheim CA 92807
A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma Alameda CA 94602
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma Wheat Ridge CO
BI 671800 ED in Steroid-naive Asthmatic Patients Wheat Ridge CO
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Wheat Ridge CO
BI 671800 ED in Steroid-naive Asthmatic Patients Lakewood CO
Cell Biology of Steroid Resistant Asthma Denver CO 80206
Lansoprazole to Treat Children With Asthma Denver CO 80206
Markers of Airway Inflammation in BAL Fluid From Children With Asthma Denver CO 80206

Showing 1-100 of 753
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register